Day One Biopharmaceuticals Inc

NASDAQ:DAWN   3:55:37 PM EDT
21.26
+0.91 (+4.47%)
Earnings Announcements

Day One Biopharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.53

Published: 11/07/2022 22:11 GMT
Day One Biopharmaceuticals Inc (DAWN) - Day One Reports Third Quarter 2022 Financial Results and Corporate Progress.
Day One Biopharmaceuticals Inc - Based on Current Operating Plan, Management Believes It Has Sufficient Capital Resources to Fund Anticipated Operations Into 2025.
Day One Biopharmaceuticals Inc - Qtrly Loss per Share $0.53.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.